- Home
- VATE vs CVM Comparison
VATE vs CVM Comparison
Compare VATE & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VATE
- CVM
- Stock Information
- Founded
- VATE 1994
- CVM 1983
- Country
- VATE United States
- CVM United States
- Employees
- VATE N/A
- CVM N/A
- Industry
- VATE Metal Fabrications
- CVM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VATE Industrials
- CVM Health Care
- Exchange
- VATE Nasdaq
- CVM Nasdaq
- Market Cap
- VATE 82.6M
- CVM 68.9M
- IPO Year
- VATE 1996
- CVM 1987
- Fundamental
- Price
- VATE $4.28
- CVM $0.56
- Analyst Decision
- VATE
- CVM
- Analyst Count
- VATE 0
- CVM 0
- Target Price
- VATE N/A
- CVM N/A
- AVG Volume (30 Days)
- VATE 46.5K
- CVM 450.5K
- Earning Date
- VATE 11-06-2024
- CVM 12-19-2024
- Dividend Yield
- VATE N/A
- CVM N/A
- EPS Growth
- VATE N/A
- CVM N/A
- EPS
- VATE N/A
- CVM N/A
- Revenue
- VATE $1,231,500,000.00
- CVM N/A
- Revenue This Year
- VATE N/A
- CVM N/A
- Revenue Next Year
- VATE N/A
- CVM $3,412.81
- P/E Ratio
- VATE N/A
- CVM N/A
- Revenue Growth
- VATE N/A
- CVM N/A
- 52 Week Low
- VATE $3.25
- CVM $0.54
- 52 Week High
- VATE $14.60
- CVM $3.23
- Technical
- Relative Strength Index (RSI)
- VATE 32.82
- CVM 16.48
- Support Level
- VATE $3.78
- CVM $0.68
- Resistance Level
- VATE $4.13
- CVM $0.92
- Average True Range (ATR)
- VATE 0.45
- CVM 0.06
- MACD
- VATE -0.28
- CVM -0.02
- Stochastic Oscillator
- VATE 7.73
- CVM 0.06
About VATE INNOVATE Corp.
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting stations across the United States.
About CVM Cel-Sci Corporation
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company's core capabilities that include are drug discovery, research, development and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.